Skip to main navigation Skip to search Skip to main content

The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development

  • Masaya Baba
  • , Jonathan R. Keller
  • , Hong Wei Sun
  • , Wolfgang Resch
  • , Stefan Kuchen
  • , Hyung Chan Suh
  • , Hisashi Hasumi
  • , Yukiko Hasumi
  • , Kyong Rim Kieffer-Kwon
  • , Carme Gallego Gonzalez
  • , Robert M. Hughes
  • , Mara E. Klein
  • , Hyoungbin F. Oh
  • , Paul Bible
  • , Eileen Southon
  • , Lino Tessarollo
  • , Laura S. Schmidt
  • , W. Marston Linehan
  • , Rafael Casellas
  • National Institutes of Health
  • CSIC - Molecular Biology Institute of Barcelona
  • SAIC

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Abstract

Birt-Hogg-Dubé (BHD) syndrome is an autosomal dominant disorder characterized by cutaneous fibrofolliculomas, pulmonary cysts, and kidney malignancies. Affected individuals carry germ line mutations in folliculin (FLCN), a tumor suppressor gene that becomes biallelically inactivated in kidney tumors by second-hit mutations. Similar to other factors implicated in kidney cancer, FLCN has been shown to modulate activation of mammalian target of rapamycin (mTOR). However, its precise in vivo function is largely unknown because germ line deletion of Flcn results in early embryonic lethality in animal models. Here, we describe mice deficient in the newly characterized folliculin-interacting protein 1 (Fnip1). In contrast to Flcn, Fnip1-/- mice develop normally, are not susceptible to kidney neoplasia, but display a striking pro-B cell block that is entirely independent of mTOR activity.We show that this developmental arrest results from rapid caspase-induced pre-B cell death, and that a Bcl2 transgene reconstitutes mature B-cell populations, respectively.We also demonstrate that conditional deletion of Flcn recapitulates the pro-B cell arrest of Fnip1-/- mice. Our studies thus demonstrate that the FLCN-FNIP complex deregulated in BHD syndrome is absolutely required for B-cell differentiation, and that it functions through both mTOR-dependent and independent pathways.

Original languageEnglish
Pages (from-to)1254-1261
Number of pages8
JournalBlood
Volume120
Issue number6
DOIs
StatePublished - 9 Aug 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development'. Together they form a unique fingerprint.

Cite this